Hints and tips:
Showing results for Classen Immunotherapies, Inc.
...Data released by Moderna on Tuesday showed that a combination of the company’s experimental cancer vaccine and Merck’s immunotherapy drug Keytruda reduced the risk of death or recurrence of melanoma in high-risk...
...Drug developers have pushed cancer into retreat with immunotherapy medicines....
...Merck focuses on immunotherapy, helping the body’s own immune system to fight cancer cells....
...Merck’s cancer immunotherapy Keytruda is a wonder drug that has transformed not just the survival odds of thousands of patients but also the pharmaceutical company’s fortunes....
...Merck, the US pharma company, has been a pioneer in immunotherapy — using the immune system to target tumours — with its blockbuster drug Keytruda....
...So far, the drug has rung up just $20.1m in sales in the first two months of launch, and is not the only breast cancer immunotherapy available....
...Capitol (FT) Top US banks set for $10bn round of buybacks (FT) KKR joins music rights party with Ryan Tedder deal (FT) Dr Martens owner Permira plans IPO of cult bootmaker (FT + Lex) Sanofi acquires immunotherapy...
...At separate universities, they took almost identical routes, combining a medical degree with a doctorate programme: Dr Tureci’s in molecular biology, Dr Sahin’s in immunotherapy....
...Even as the company’s best-selling drug, the cancer immunotherapy Keytruda, has drastically improved survival odds for thousands of people, Mr Frazier has tended to take a back seat, leaving the company’...
...“One of the most important issues we are dealing with in immunotherapy right now is who is going to respond, versus who is not,” she said....
...The company is preparing to launch breast cancer immunotherapy Ibrance, sales of which soared 25 per cent globally in the first quarter, in China....
...Keytruda is an immunotherapy, a treatment that works by harnessing the body’s own immune system against the cancer....
...Siddhartha Mukherjee, the cancer geneticist and Pulitzer Prize-winning writer who is working on a novel way to expand immunotherapies for blood cancers, has raised $42m for his start-up Vor Biopharma....
...Immunotherapy is a crowded market. The techniques under development are in their infancy. Yet Kite was a spectacular illustration of what can be achieved....
...Growth in the former was driven by a “significant increase” in sales of cancer immunotherapy drug Keytruda....
...Brad Loncar, who runs exchange traded funds focused on cancer immunotherapies and Chinese biotech, said it was in the “top five most exciting days” for biotech investors in more than a decade....
...Merck’s drug, Keytruda, generated $1.667bn of revenues in the second quarter of the year, compared to $1.627bn for Bristol’s competing immunotherapy, Opdivo....
...US pharmaceuticals company Merck has increased its quarterly dividend by 15 per cent and authorised an additional $10bn of treasury stock purchases, as it reaps the rewards of its cancer immunotherapy drug...
...Keytruda and Opdivo are enormously important drugs in the developing field of cancer immunotherapy. They are “checkpoint inhibitors” that prevent the body blocking an immune response to cancer cells....
...While a minority of between 20 and 30 per cent of cancer patients do extremely well on immunotherapies, most do not....
...Merck cemented its position as the dominant developer of immunotherapy after a large clinical trial showed lung cancer patients taking its drug lived for longer than those on chemotherapy....
...The findings mean that from now on most untreated lung cancer patients will be given an immunotherapy by default....
...The quest to expand the benefits of cancer immunotherapy to more patients suffered a big setback on Friday following the failure of a closely followed clinical trial....
...Immunotherapies work by allowing the body’s own immune system to attack tumour cells....
...Keytruda is seen as promising, and Merck shares jumped in April when the company said a late stage trial of the immunotherapy drug showed it helped prolong the lives of patients with a certain type of lung...
International Edition